KR101842309B1 - 활성물질을 투여하기 위한 경피용 치료학적 시스템 - Google Patents

활성물질을 투여하기 위한 경피용 치료학적 시스템 Download PDF

Info

Publication number
KR101842309B1
KR101842309B1 KR1020137016047A KR20137016047A KR101842309B1 KR 101842309 B1 KR101842309 B1 KR 101842309B1 KR 1020137016047 A KR1020137016047 A KR 1020137016047A KR 20137016047 A KR20137016047 A KR 20137016047A KR 101842309 B1 KR101842309 B1 KR 101842309B1
Authority
KR
South Korea
Prior art keywords
layer
therapeutic system
transdermal therapeutic
active material
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137016047A
Other languages
English (en)
Korean (ko)
Other versions
KR20130129988A (ko
Inventor
브리타 랑거
비요른 스츄라드
하이케 프린츠
Original Assignee
루예 파마 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 루예 파마 아게 filed Critical 루예 파마 아게
Publication of KR20130129988A publication Critical patent/KR20130129988A/ko
Application granted granted Critical
Publication of KR101842309B1 publication Critical patent/KR101842309B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020137016047A 2010-12-14 2011-12-14 활성물질을 투여하기 위한 경피용 치료학적 시스템 Active KR101842309B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10194968.3 2010-12-14
EP10194968.3A EP2468274B1 (de) 2010-12-14 2010-12-14 Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
PCT/EP2011/072812 WO2012080365A1 (de) 2010-12-14 2011-12-14 Transdermales therapeutisches system zur verabreichung eines wirkstoffs

Publications (2)

Publication Number Publication Date
KR20130129988A KR20130129988A (ko) 2013-11-29
KR101842309B1 true KR101842309B1 (ko) 2018-03-26

Family

ID=43836835

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137016047A Active KR101842309B1 (ko) 2010-12-14 2011-12-14 활성물질을 투여하기 위한 경피용 치료학적 시스템

Country Status (25)

Country Link
US (2) US10660863B2 (enExample)
EP (2) EP2468274B1 (enExample)
JP (1) JP6043296B2 (enExample)
KR (1) KR101842309B1 (enExample)
CN (3) CN107412202A (enExample)
AU (2) AU2011343363B2 (enExample)
BR (1) BR112013014616B1 (enExample)
CA (2) CA3065240C (enExample)
CY (2) CY1116638T1 (enExample)
DK (2) DK2468274T3 (enExample)
EA (1) EA026520B1 (enExample)
ES (2) ES2545094T3 (enExample)
HK (1) HK1243336A1 (enExample)
HR (2) HRP20201880T1 (enExample)
HU (2) HUE027916T2 (enExample)
LT (1) LT2651410T (enExample)
MX (1) MX345344B (enExample)
MY (1) MY183873A (enExample)
PL (2) PL2468274T3 (enExample)
PT (2) PT2468274E (enExample)
RS (2) RS54173B1 (enExample)
SI (2) SI2468274T1 (enExample)
SM (2) SMT202000638T1 (enExample)
WO (1) WO2012080365A1 (enExample)
ZA (1) ZA201303965B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012000369A1 (de) * 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
DE102012016317A1 (de) * 2012-08-14 2014-02-20 Jenabatteries GmbH Redox-Flow-Zelle zur Speicherung elektrischer Energie
EP2884969A1 (en) * 2012-08-15 2015-06-24 Dow Corning Corporation Multi - layer transdermal drug delivery system
WO2014111790A2 (en) * 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
US20240082065A1 (en) * 2016-07-08 2024-03-14 Moteah Williams Waterproof and transparent wound barrier and method of manufacturing same
EP3501518B1 (en) 2016-08-22 2025-05-14 Kyukyu Pharmaceutical Co., Ltd. Transdermal patch of rivastigmine
WO2019017266A1 (ja) * 2017-07-19 2019-01-24 帝國製薬株式会社 リバスチグミン含有経皮吸収型製剤
DE102018120506A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US20210038532A1 (en) * 2018-03-13 2021-02-11 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system comprising a silicone acrylic hybrid polymer
WO2019220697A1 (ja) * 2018-05-17 2019-11-21 パナソニックＩｐマネジメント株式会社 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法
ES2923891T3 (es) 2018-08-08 2022-10-03 Danapak Flexibles As Películas y láminas mejoradas para usarse en el envase de compuestos reactivos
JP7549642B2 (ja) * 2019-07-09 2024-09-11 エルテーエス ローマン テラピー－ジステーメ アーゲー アクリルポリマーを含む活性剤含有層及びシリコーンゲル接着剤を含む皮膚接触層を含む経皮治療システム
CN113616625B (zh) * 2021-08-26 2023-05-30 大连科翔科技开发有限公司 一种卡巴拉汀的长效透皮贴剂
DE102021128912A1 (de) * 2021-11-05 2023-05-11 Lts Lohmann Therapie-Systeme Ag. Okklusives pflaster mit flexibler backing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
JPH08502727A (ja) * 1992-08-25 1996-03-26 シグナス セラピューティック システムズ プリントされた経皮薬剤送達デバイス
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
GB9800526D0 (en) 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
US6348210B1 (en) * 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
NZ582975A (en) * 2004-10-21 2011-07-29 Durect Corp Transdermal delivery systems delivering sufentanil
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CN101351233A (zh) * 2005-12-30 2009-01-21 科洛普拉斯特公司 具有可塑的层作为皮肤接触表面的层状粘合构造
CN101304735A (zh) * 2006-01-12 2008-11-12 Lts勒曼治疗系统股份公司 用于挥发性和/或热不稳定的物质的经皮治疗体系
KR20090009951A (ko) * 2006-05-08 2009-01-23 데이고꾸세이약꾸가부시끼가이샤 항치매제를 포함하는 경피 흡수 제제
US9248104B2 (en) 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009009651A1 (en) 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with ultrasonic weld
JP5546013B2 (ja) * 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2010126450A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
MX350357B (es) * 2009-12-22 2017-09-05 Luye Pharma Ag Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009026135A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
US12318360B2 (en) 2018-08-31 2025-06-03 Sk Chemicals Co., Ltd. Rivastigmine patch for long-term administration

Also Published As

Publication number Publication date
SMT202000638T1 (it) 2021-01-05
HRP20150881T1 (hr) 2015-09-25
EP2651410B1 (de) 2020-10-14
JP2014503523A (ja) 2014-02-13
EA026520B1 (ru) 2017-04-28
ZA201303965B (en) 2014-09-25
AU2011343363B2 (en) 2017-06-08
RS54173B1 (sr) 2015-12-31
EA201300704A1 (ru) 2014-01-30
EP2651410A1 (de) 2013-10-23
JP6043296B2 (ja) 2016-12-14
HK1243336A1 (zh) 2018-07-13
HRP20201880T1 (hr) 2021-02-05
PL2651410T3 (pl) 2021-03-08
CA2817461C (en) 2020-02-25
MX345344B (es) 2017-01-26
PT2651410T (pt) 2020-12-15
US20200289426A1 (en) 2020-09-17
ES2836483T3 (es) 2021-06-25
MX2013005581A (es) 2013-08-26
CA3065240A1 (en) 2012-06-21
RS61155B1 (sr) 2020-12-31
AU2017213569B2 (en) 2019-04-11
CN113244199A (zh) 2021-08-13
DK2468274T3 (en) 2015-08-31
PL2468274T3 (pl) 2015-11-30
LT2651410T (lt) 2020-12-28
SI2651410T1 (sl) 2021-01-29
DK2651410T3 (da) 2020-11-02
SI2468274T1 (sl) 2015-10-30
WO2012080365A1 (de) 2012-06-21
CN103269698B (zh) 2017-07-14
MY183873A (en) 2021-03-17
HUE027916T2 (en) 2016-11-28
PT2468274E (pt) 2015-09-21
SMT201500184B (it) 2015-09-07
CY1116638T1 (el) 2017-03-15
ES2545094T3 (es) 2015-09-08
AU2017213569A1 (en) 2017-08-31
US10660863B2 (en) 2020-05-26
BR112013014616A2 (pt) 2016-09-20
AU2011343363A1 (en) 2013-06-20
HUE052137T2 (hu) 2021-04-28
BR112013014616B1 (pt) 2021-12-21
CN107412202A (zh) 2017-12-01
EP2468274A1 (de) 2012-06-27
CA2817461A1 (en) 2012-06-21
CA3065240C (en) 2022-02-15
US20140323996A1 (en) 2014-10-30
CY1123712T1 (el) 2022-03-24
EP2468274B1 (de) 2015-07-01
CN103269698A (zh) 2013-08-28
KR20130129988A (ko) 2013-11-29

Similar Documents

Publication Publication Date Title
KR101842309B1 (ko) 활성물질을 투여하기 위한 경피용 치료학적 시스템
KR101674240B1 (ko) 리바스티그민 또는 그의 유도체 투여용 경피 치료 시스템
JP5632577B2 (ja) 貼付剤
US10076502B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
HK1187247B (en) Transdermal therapeutic system for administering an active substance
HK1187247A (en) Transdermal therapeutic system for administering an active substance
HK1170945A (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
HK1170945B (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130620

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20161122

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170616

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180109

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170616

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180109

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20171016

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20161122

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20180302

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20180214

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20180109

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20171016

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20161122

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180320

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180320

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210311

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220314

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240312

Start annual number: 7

End annual number: 7